Emmanuel Griessinger

Author

Inserm ORCID

Also Known As

E Griessinger, E. Griessinger, Emmanuel F Griessinger, Emmanuel Griessinger, Griessinger, E., Griessinger, Emmanuel

Publications

Citations

H-Index

Concepts

All Affiliations

Inserm Cancer Research UK Université Côte d'Azur Queen Mary University of London Centre Méditerranéen de Médecine Moléculaire

About

Emmanuel Griessinger is an author at Inserm specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	902
2	Cell Biology	10	11	798
3	Health Sciences	4	4	459
4	Engineering	1	1	10
5	Biomedical Engineering	1	1	10

Emmanuel Griessinger

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism Thomas Farge, Estelle Saland, Fabienne de Toni, Cancer Discovery	2017	877
Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells Lionel Franz Poulin, Mariolina Salio, Emmanuel Griessinger, The Journal of Experimental Medicine	2010	645
Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy Ruxanda Moschoi, Véronique Imbert, Marielle Nebout, Blood	2016	438
Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34− fraction David Taussig, Jacques Vargaftig, Farideh Miraki‐Moud, Blood	2010	356
β-Catenin Mediates the Establishment and Drug Resistance of MLL Leukemic Stem Cells Jenny Yeung, Maria Teresa Esposito, Arnaud Gandillet, Cancer Cell Hematological MalignancyHealth SciencesMedicineStem Cell ToxicologyPharmacology	2010	271
Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation Farideh Miraki‐Moud, Fernando Anjos‐Afonso, Katharine Hodby, Proceedings of the National Academy of Sciences	2013	146
L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia Célia Rosilio, Marielle Nebout, Véronique Imbert, Leukemia Lymphoid NeoplasiaImmunologyAdult T-cell Leukemia-lymphomaImmunotherapyMedicine	2014	126
“Microenvironmental contaminations” induced by fluorescent lipophilic dyes used for noninvasive in vitro and in vivo cell tracking François Lassailly, Emmanuel Griessinger, Dominique Bonnet Blood	2010	122
A Niche-Like Culture System Allowing the Maintenance of Primary Human Acute Myeloid Leukemia-Initiating Cells: A New Tool to Decipher Their Chemoresistance and Self-Renewal Mechanisms Emmanuel Griessinger, Fernando Anjos‐Afonso, Irene Pizzitola, Stem Cells Translational Medicine Hematological MalignancyDevelopmental BiologyNew ToolMedicineMixed-phenotype Acute Leukemia	2014	112
A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia Estelle Saland, Héléna Boutzen, Rémy Castellano, Blood Cancer Journal	2015	84

Page 1